Outset Net Income Applicable To Common Shares from 2010 to 2026

OM Stock  USD 3.39  0.41  10.79%   
Outset Medical Net Loss yearly trend continues to be very stable with very little volatility. Net Loss is likely to drop to about -154 M. Net Loss is the net income that remains after preferred dividends have been deducted, available to common shareholders. View All Fundamentals
 
Net Loss  
First Reported
2010-12-31
Previous Quarter
-146.7 M
Current Value
-154 M
Quarterly Volatility
39.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Outset Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Outset Medical's main balance sheet or income statement drivers, such as Tax Provision of 592.9 K, Interest Income of 11.8 M or Depreciation And Amortization of 4.8 M, as well as many indicators such as Price To Sales Ratio of 0.45, Dividend Yield of 0.0 or PTB Ratio of 0.42. Outset financial statements analysis is a perfect complement when working with Outset Medical Valuation or Volatility modules.
  
Build AI portfolio with Outset Stock
Check out the analysis of Outset Medical Correlation against competitors.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.
Evaluating Outset Medical's Net Income Applicable To Common Shares across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Outset Medical's fundamental strength.

Latest Outset Medical's Net Income Applicable To Common Shares Growth Pattern

Below is the plot of the Net Income Applicable To Common Shares of Outset Medical over the last few years. It is the net income that remains after preferred dividends have been deducted, available to common shareholders. Outset Medical's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Outset Medical's overall financial position and show how it may be relating to other accounts over time.
Net Income Applicable To Common Shares10 Years Trend
Slightly volatile
   Net Income Applicable To Common Shares   
       Timeline  

Outset Net Income Applicable To Common Shares Regression Statistics

Arithmetic Mean(102,585,989)
Coefficient Of Variation(38.57)
Mean Deviation35,993,045
Median(73,080,000)
Standard Deviation39,568,037
Sample Variance1565.6T
Range89.9M
R-Value(0.85)
Mean Square Error468.3T
R-Squared0.72
Significance0.000017
Slope(6,646,922)
Total Sum of Squares25050.1T

Outset Net Income Applicable To Common Shares History

2026-154 M
2025-146.7 M
2022-163 M
2021-131.9 M
2020-79.3 M
2019-85.5 M

About Outset Medical Financial Statements

Outset Medical investors utilize fundamental indicators, such as Net Income Applicable To Common Shares, to predict how Outset Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Net Loss-146.7 M-154 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
Check out the analysis of Outset Medical Correlation against competitors.
To learn how to invest in Outset Stock, please use our How to Invest in Outset Medical guide.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could Outset diversify its offerings? Factors like these will boost the valuation of Outset Medical. Anticipated expansion of Outset directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Outset Medical data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(5.37)
Revenue Per Share
10.395
Quarterly Revenue Growth
0.027
Return On Assets
(0.15)
Return On Equity
(0.92)
Outset Medical's market price often diverges from its book value, the accounting figure shown on Outset's balance sheet. Smart investors calculate Outset Medical's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Outset Medical's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Outset Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Outset Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Outset Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.